Your browser is no longer supported. Please, upgrade your browser.
Settings
OPHT Ophthotech Corporation daily Stock Chart
OPHT [NASD]
Ophthotech Corporation
Index- P/E2.17 EPS (ttm)1.57 Insider Own0.20% Shs Outstand35.97M Perf Week9.35%
Market Cap121.94M Forward P/E- EPS next Y-2.05 Insider Trans-32.48% Shs Float35.93M Perf Month37.25%
Income57.50M PEG- EPS next Q-0.80 Inst Own64.80% Short Float3.93% Perf Quarter21.07%
Sales215.30M P/S0.57 EPS this Y-78.30% Inst Trans-2.18% Short Ratio2.15 Perf Half Y39.51%
Book/sh1.22 P/B2.78 EPS next Y-1763.60% ROA24.90% Target Price3.83 Perf Year-90.61%
Cash/sh5.01 P/C0.68 EPS next 5Y- ROE-69.40% 52W Range2.24 - 40.34 Perf YTD-29.81%
Dividend- P/FCF- EPS past 5Y21.50% ROI206.30% 52W High-91.60% Beta1.37
Dividend %- Quick Ratio12.90 Sales past 5Y- Gross Margin- 52W Low51.34% ATR0.20
Employees156 Current Ratio12.90 Sales Q/Q-94.10% Oper. Margin26.00% RSI (14)75.82 Volatility6.05% 7.15%
OptionableYes Debt/Eq0.00 EPS Q/Q406.60% Profit Margin26.70% Rel Volume0.93 Prev Close3.29
ShortableYes LT Debt/Eq0.00 EarningsNov 08 BMO Payout0.00% Avg Volume656.11K Price3.39
Recom3.00 SMA2027.30% SMA5029.11% SMA20016.04% Volume608,391 Change3.04%
Dec-13-16Upgrade Goldman Sell → Neutral
Dec-13-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-13-16Downgrade Gabelli & Co Buy → Hold
Dec-12-16Downgrade Leerink Partners Outperform → Mkt Perform
Dec-12-16Downgrade JP Morgan Overweight → Neutral
Dec-12-16Downgrade Citigroup Buy → Neutral
Dec-12-16Downgrade Chardan Capital Markets Buy → Neutral $200 → $15
Jun-02-16Upgrade JP Morgan Neutral → Overweight
Apr-27-16Initiated Barclays Overweight $85
Jan-08-16Initiated Sun Trust Rbsn Humphrey Buy $100
Jan-07-16Initiated Sun Trust Rbsn Humphrey Buy
Dec-14-15Reiterated Chardan Capital Markets Buy $125 → $200
Sep-08-15Reiterated Chardan Capital Markets Buy $105 → $125
Sep-03-15Initiated Citigroup Buy
Aug-14-15Resumed Oppenheimer Outperform $95
Aug-07-15Downgrade Goldman Neutral → Sell
Aug-06-15Reiterated Stifel Buy $74 → $83
Aug-03-15Reiterated Leerink Partners Outperform $69 → $92
Jul-07-15Initiated Cowen Outperform $80
May-12-15Reiterated Chardan Capital Markets Buy $95 → $105
Nov-21-17 07:50AM  Report: Exploring Fundamental Drivers Behind Carter's, Southern Copper, ViaSat, Bruker, Fred's, and Ophthotech New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-20-17 01:01PM  ETFs with exposure to Ophthotech Corp. : November 20, 2017 Capital Cube
Nov-14-17 08:43AM  Ophthotech (OPHT) Jumps: Stock Rises 11.9% Zacks
Nov-13-17 08:31PM  Edited Transcript of OPHT earnings conference call or presentation 8-Nov-17 1:00pm GMT Thomson Reuters StreetEvents +11.89%
02:20PM  Vertex Gets CHMP Recommendation for Orkambi Label Expansion Zacks
Nov-10-17 12:46PM  ETFs with exposure to Ophthotech Corp. : November 10, 2017 Capital Cube
Nov-09-17 09:48AM  Ophthotech Corp. :OPHT-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017 Capital Cube
09:16AM  Ophthotech (OPHT) Q3 Earnings & Sales Beat, Zimura in Focus Zacks
08:10AM  Todays Research Reports on Stocks to Watch: Ophthotech Corporation and HTG Molecular Diagnostics ACCESSWIRE
Nov-08-17 09:30AM  Ophthotech Soars After Third-Quarter Results -- Biotech Movers TheStreet.com +15.88%
07:22AM  Ophthotech posts 3Q profit Associated Press
07:00AM  Ophthotech Reports Third Quarter 2017 Financial and Operating Results Business Wire
06:00AM  Ophthotech Corp. to Host Earnings Call ACCESSWIRE
Oct-30-17 07:30AM  Ophthotech Corporation to Report Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017 Business Wire
Oct-09-17 02:19PM  How Should You Think About Ophthotech Corporations (OPHT) Risks? Simply Wall St.
Sep-21-17 10:15AM  How is the Age-Related Macular Degeneration Space Faring Now? Zacks
Sep-19-17 07:00AM  Ophthotech Provides Update on Zimura® Complement Programs for Treatment of Eye Diseases Business Wire
Sep-11-17 09:42AM  Roche's Ophthalmology Drug Fails to Meet Primary Endpoint Zacks
Sep-08-17 01:01PM  Roche shares decline 1.6% on news that late-stage study missed primary endpoint MarketWatch -14.52%
Aug-29-17 06:49AM  Why Is Ophthotech (OPHT) Up 7.4% Since the Last Earnings Report? Zacks
Aug-16-17 10:23AM  Ophthotech's Fovista Combo Regimen Disappoints in Phase III Zacks
Aug-14-17 09:38AM  Biotech movers: CEL-SCI Leaps After FDA Lets Cancer Study Move Forward TheStreet.com +6.27%
06:30AM  Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration Business Wire
Aug-12-17 11:56AM  Edited Transcript of OPHT earnings conference call or presentation 26-Jul-17 12:00pm GMT Thomson Reuters StreetEvents
Jul-27-17 10:28AM  Ophthotech (OPHT) Q2 Loss Narrows, Focus Shifts to Zimura Zacks -6.64%
Jul-26-17 03:23PM  Ophthotech reports 2Q loss Associated Press
06:45AM  Investor Network: Ophthotech Corp. to Host Earnings Call Accesswire
06:33AM  Ophthotech Reports Second Quarter 2017 Financial and Operating Results Business Wire
06:30AM  Ophthotech Expands Focus with Development for Ophthalmic Orphan Diseases Business Wire
Jul-21-17 07:30AM  Ophthotech Corporation to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, July 26, 2017 Business Wire
Jun-06-17 03:59AM  Why Is Ophthotech (OPHT) Down 13.7% Since the Last Earnings Report? Zacks
May-18-17 03:59PM  Edited Transcript of OPHT earnings conference call or presentation 3-May-17 12:00pm GMT Thomson Reuters StreetEvents
May-15-17 09:00PM  Newman Ferrara LLP Announces Corporate Governance Investigation of Ophthotech Corp. - OPHT Business Wire
May-04-17 10:48AM  Ophthotech (OPHT) Q1 Loss Narrower than Expected, Sales Miss Zacks
May-03-17 07:46PM  Edited Transcript of OPHT earnings conference call or presentation 3-May-17 12:00pm GMT Thomson Reuters StreetEvents
07:52AM  Ophthotech reports 1Q loss Associated Press
07:30AM  Ophthotech Reports First Quarter 2017 Financial and Operating Results Business Wire
07:05AM  Investor Network: Ophthotech Corp. to Host Earnings Call Accesswire
May-01-17 04:15PM  ETFs with exposure to Ophthotech Corp. : May 1, 2017 Capital Cube
Apr-26-17 07:30AM  Ophthotech Corporation to Report First Quarter 2017 Financial Results and Host Conference Call on Wednesday, May 3, 2017 Business Wire
Apr-24-17 04:15PM  Ophthotech Announces Leadership Transition Effective July 1, 2017 Business Wire
Apr-19-17 02:29PM  ETFs with exposure to Ophthotech Corp. : April 19, 2017 Capital Cube
Apr-07-17 05:14PM  ETFs with exposure to Ophthotech Corp. : April 7, 2017 Capital Cube
Mar-31-17 07:45AM  Ophthotech (OPHT) Down 2.9% Since Earnings Report: Can It Rebound? Zacks
07:01AM  OPHTHOTECH CORP. Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders
Mar-27-17 04:02PM  ETFs with exposure to Ophthotech Corp. : March 27, 2017 Capital Cube
04:02PM  ETFs with exposure to Ophthotech Corp. : March 27, 2017
Mar-20-17 08:37AM  Ophthotech Corp. :OPHT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube
08:37AM  Ophthotech Corp. :OPHT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
Mar-14-17 02:55PM  Ophthotech Corp. :OPHT-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Capital Cube
02:55PM  Ophthotech Corp. :OPHT-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
Mar-10-17 10:50PM  OPHTHOTECH 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Ophthotech Corporation (OPHT) Business Wire
Mar-09-17 11:33AM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-08-17 02:47PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
11:59AM  INVESTOR COMPLAINT: Levi & Korsinsky, LLP Reminds Investors of Ophthotech Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 GlobeNewswire
Mar-07-17 01:04PM  OPHTHOTECH CORP. Financials
10:30AM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ophthotech Corporation (OPHT) & Lead Plaintiff Deadline: March 13, 2017 GlobeNewswire
Mar-06-17 04:31PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Ophthotech Corporation and Certain Officers OPHT GlobeNewswire
12:17PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-03-17 10:50PM  OPHTHOTECH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Ophthotech Corporation (OPHT) GlobeNewswire
04:09PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Ophthotech Corporation to Contact the Firm Before Imminent Lead Plaintiff Deadline Accesswire
10:49AM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Ophthotech Corporation, and Encourages Investors with Losses to Contact the Firm Accesswire
09:33AM  SHAREHOLDER COMPLAINT: Levi & Korsinsky, LLP Reminds Investors of Ophthotech Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 Business Wire
09:00AM  DEADLINE ALERT: Brower Piven Reminds Investors Of The March 13, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Ophthotech Corporation (OPHT) To Contact The Firm GlobeNewswire
08:39AM  Are Options Traders Betting on a Big Move in Ophthotech (OPHT) Stock?
Mar-01-17 10:45AM  Ophthotech Hits 52-Week Low on 4Q Loss, Updates at Investopedia +5.03%
09:40AM  Ophthotech (OPHT) Q4 Loss Wider than Expected, Sales Miss
Feb-28-17 07:17AM  Ophthotech reports 4Q loss -21.66%
07:07AM  OPHTHOTECH CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:07AM  Q4 2016 Ophthotech Corp Earnings Release - Before Market Open
07:00AM  Ophthotech Reports Fourth Quarter and Full Year 2016 Financial and Operating Results Business Wire
Feb-27-17 08:38PM  [$$] Medical Megadeals Dominate Deal Flow at The Wall Street Journal +7.78%
11:25AM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
10:02AM  OPHT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ophthotech Corporation and a Lead Plaintiff Deadline of March 13, 2017 Business Wire
Feb-24-17 04:16PM  OPHTHOTECH CORP. Files SEC form 8-K, Change in Directors or Principal Officers
Feb-22-17 05:53PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Ophthotech Corporation, and Encourages Investors with Losses to Contact the Firm Accesswire
03:28PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Ophthotech Corporation To Contact The Firm Before Lead Plaintiff Deadline PR Newswire
11:34AM  OPHT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Ophthotech Corporation and a Lead Plaintiff Deadline of March 13, 2017 PR Newswire
07:30AM  Ophthotech Corporation to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call on Tuesday, February 28, 2017 Business Wire
Feb-20-17 10:17AM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
Feb-17-17 10:50PM  OPHTHOTECH SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Ophthotech Corporation (OPHT) Business Wire
10:36AM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
09:45AM  INVESTOR COMPLAINT: Levi & Korsinsky, LLP Reminds Investors of Ophthotech Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 Business Wire
Feb-13-17 02:51PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
01:27PM  OPHT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ophthotech Corporation and a Lead Plaintiff Deadline of March 13, 2017 Business Wire
Feb-08-17 04:15PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Ophthotech Corporation, and Encourages Investors with Losses to Contact the Firm Accesswire
03:27PM  DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Ophthotech Corporation To Contact The Firm Business Wire
01:36PM  OPHT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ophthotech Corporation and a Lead Plaintiff Deadline of March 13, 2017 GlobeNewswire
Feb-07-17 11:41AM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ophthotech Corporation (OPHT) & Lead Plaintiff Deadline - March 13, 2017 GlobeNewswire
Feb-04-17 09:31AM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Ophthotech Corporation, and Encourages Investors with Losses to Contact the Firm Accesswire
Feb-03-17 10:50PM  OPHTHOTECH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Ophthotech Corporation - (OPHT) PR Newswire
06:09PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
11:39AM  SHAREHOLDER COMPLAINT: Levi & Korsinsky, LLP Reminds Investors of Ophthotech Corporation of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 GlobeNewswire
Feb-02-17 03:01PM  Ophthotech Hires Adviser, Mulls Strategic Options at Investopedia
Feb-01-17 07:02AM  OPHTHOTECH CORP. Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or Principal
06:30AM  Ophthotech Announces Strategic Review Plan Business Wire
Jan-30-17 08:03PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Ophthotech Corporation, and Encourages Investors with Losses to Contact the Firm Accesswire
07:01PM  Robbins Arroyo LLP: Ophthotech Corporation (OPHT) Misled Shareholders According to a Recently Filed Class Action Business Wire
Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate, Fovista, an anti-platelet derived growth factor, is in Phase III clinical development for use in combination with anti-vascular endothelial growth factor drugs for the treatment of wet age-related macular degeneration (AMD). The company is also developing Zimura, an inhibitor of complement factor C5, for the treatment of dry AMD and wet AMD. Ophthotech Corporation was founded in 2007 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carroll David FrancisSVP, CFO and TreasurerJul 05Sale2.583,2848,4734,216Jul 05 06:35 PM
GUYER DAVID RExecutive ChairmanJul 05Sale2.5817,67845,60920,014Jul 05 06:34 PM
WOOD BARBARA ASVP,General Counsel,SecretaryJul 05Sale2.585,11913,2078,332Jul 05 06:33 PM
SBLENDORIO GLENNPresident and CEOJul 05Sale2.587,82820,19624,164Jul 05 06:31 PM
Redlick David EDirectorJun 13Sale2.527001,7641,050Jun 14 07:17 PM
SBLENDORIO GLENNPresident, CFO and TreasurerApr 03Sale3.567,38826,30111,572Apr 04 07:10 PM
WOOD BARBARA ASVP,General Counsel,SecretaryJan 05Sale4.965892,9211,311Jan 06 05:14 PM
GUYER DAVID RChief Executive OfficerJan 05Sale4.963,78518,7747,212Jan 06 05:14 PM
Bjarke Henric BjornSVP & CCOJan 05Sale4.963161,5671,384Jan 06 05:12 PM
PATEL SAMIR CHANDRAKANTPresidentJan 05Sale4.963,84419,06615,813Jan 06 05:13 PM
PATEL SAMIR CHANDRAKANTPresidentJan 03Sale4.902,99914,69513,407Jan 04 05:06 PM
WOOD BARBARA ASVP, General Counsel,SecretaryJan 03Sale4.906753,308700Jan 04 05:05 PM
GUYER DAVID RChief Executive OfficerJan 03Sale4.903,48417,0724,747Jan 04 05:06 PM
Bolte AxelDirectorDec 30Sale4.836,00028,9800Jan 23 05:05 PM
WOOD BARBARA ASVP,General Counsel,SecretaryDec 23Sale4.927463,6700Dec 27 05:10 PM
SBLENDORIO GLENNEVP, COO & CFO, TreasurerDec 22Sale4.851,0795,2360Dec 23 05:05 PM
Novo A/S10% OwnerDec 15Sale4.721,405,4876,636,0070Dec 16 06:29 PM
Novo A/S10% OwnerDec 14Sale4.972,205,00010,962,3781,405,487Dec 16 06:29 PM